Evidence map›Paper›PMID 34982358›Full record

ReviewMolecular diversity2022

Camphor nitroimine: a key building block in unusual transformations and its applications in the synthesis of bioactive compounds.

Emerson Teixeira da Silva, Luciano da Silva Santos, Gabriel Fernandes de Andrade, Emerson Joaquim Rodrigues Rosa, Marcus Vinícius Nora de Souza

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular diversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emerson Teixeira da SilvaLaboratório de Síntese de Substâncias contra Doenças Tropicais-SSCDT, Departamento de Fármacos, Farmanguinhos-Fiocruz, Rio de Janeiro, Brazil.
Luciano da Silva SantosLaboratório de Síntese de Substâncias contra Doenças Tropicais-SSCDT, Departamento de Fármacos, Farmanguinhos-Fiocruz, Rio de Janeiro, Brazil.
Gabriel Fernandes de AndradeLaboratório de Síntese de Substâncias contra Doenças Tropicais-SSCDT, Departamento de Fármacos, Farmanguinhos-Fiocruz, Rio de Janeiro, Brazil.
Emerson Joaquim Rodrigues RosaLaboratório de Síntese de Substâncias contra Doenças Tropicais-SSCDT, Departamento de Fármacos, Farmanguinhos-Fiocruz, Rio de Janeiro, Brazil.
Marcus Vinícius Nora de SouzaLaboratório de Síntese de Substâncias contra Doenças Tropicais-SSCDT, Departamento de Fármacos, Farmanguinhos-Fiocruz, Rio de Janeiro, Brazil. mvndesouza@gmail.com.ORCID http://orcid.org/0000-0003-1566-8110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of new drugs requires a lot of time and high financial investments. It involves a research network in which there is the participation of several researchers from different areas. For a new drug to reach the market, thousands of substances must be evaluated. There are several tools for this and the use of suitable building blocks can facilitate the process by allowing a lead compound to have suitable parameters. These compounds are key structures containing special functional groups that also permit adequate synthetic transformations, leading to several structures of interest in a short period of time. In this review, the use of camphor nitroimine as a potential key building block is explored. Derived from camphor, an abundant natural product present in various plant species, this nitroimine has proved to be quite versatile, allowing the access to substances with miscellaneous biological activities, ligands to asymmetric catalysis, asymmetric oxidants, O-N transfer agents and other applications. Its easy conversion to camphecene and other derivatives is described, as well as their applications in medicinal chemistry. Druglikeness analyses were performed on these studied agents as well as on their bioactive derivatives in order to assess their use in the development of potential drugs.

Indexed as

Biological ProductsCamphorCatalysisBiological ProductsCamphorBiological activitiesBuilding blockCampheceneCamphorNitroimine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.